Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

TMO - Thermo Fisher Scientific - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8835561023

Lab Equipment, Reagents, Diagnostics, Laboratory Supplies, Biopharma Services

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Web URL: https://www.thermofisher.com

Drawdown (Underwater) Chart

Overall Trend and Yearly Seasonality

TMO Stock Overview

Market Cap in USD	210,799m
Sector	Healthcare
Industry	Diagnostics & Research
GiC SubIndustry	Life Sciences Tools & Services
TER	0.00%
IPO / Inception	1978-01-13

TMO Stock Ratings

Growth 5y	60.0
Fundamental	42.8
Dividend	28.0
Rel. Performance vs Sector	0.07
Analysts	4.15/5
Fair Price Momentum	595.24 USD
Fair Price DCF	522.12 USD

TMO Dividends

Dividend Yield 12m	0.24%
Yield on Cost 5y	0.52%
Dividends CAGR 5y	13.00%
Payout Consistency	36.2%

TMO Growth Ratios

Growth 12m	8.35%
Growth Correlation 12m	41%
Growth Correlation 3m	-44%
CAGR 5y	16.25%
CAGR/Mean DD 5y	1.43
Sharpe Ratio 12m	0.14
Alpha vs SP500 12m	-9.36
Beta vs SP500 5y weekly	0.80
ValueRay RSI	98.76
Volatility GJR Garch 1y	28.12%
Price / SMA 50	7.47%
Price / SMA 200	12.26%
Current Volume	2715.4k
Average Volume 20d	1873k

External Links for TMO Stock

News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle

What is the price of TMO stocks?
As of July 27, 2024, the stock is trading at USD 607.14 with a total of 2,715,365 shares traded.
Over the past week, the price has changed by +13.62%, over one month by +8.77%, over three months by +5.92% and over the past year by +10.96%.

What are the forecast for TMO stock price target?
According to ValueRays Forecast Model, TMO Thermo Fisher Scientific will be worth about 653.6 in July 2025. The stock is currently trading at 607.14. This means that the stock has a potential upside of +7.65%.

Issuer	Forecast	Upside
Wallstreet Target Price	624.9	2.93
Analysts Target Price	601.9	-0.87
ValueRay Target Price	653.6	7.65

Thermo Fisher Scientific Inc: A Comprehensive Overview

History and Evolution

Thermo Fisher Scientific Inc, recognized globally as a leader in serving science, has a rich history dating back to 1956. Its establishment marked the beginning of a new era in the scientific community, aiming to make the world healthier, cleaner, and safer. Through strategic mergers and acquisitions, most notably the merger of Thermo Electron and Fisher Scientific in 2006, the company expanded its reach and capabilities, positioning itself as a formidable force in the industry.

Core Business

At its core, Thermo Fisher is dedicated to helping its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity. It does so by providing a vast array of products and services. These include analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics.

Side Businesses and Expansion

While its primary focus is on serving the science community, Thermo Fisher Scientific has also branched into various side businesses. This includes the production of medical devices, pharmaceutical services, and biotechnology products. The company’s strategic acquisitions have allowed it to enter and thrive in these markets, further diversifying its business portfolio and reinforcing its market position.

Current Market Status

As of the latest market data, Thermo Fisher Scientific Inc (NYSE:TMO) continues to be a powerhouse in the science and technology sector. It has consistently shown growth in revenue and market share, thanks in part to its robust product line and strategic expansions. Despite facing challenges like global economic fluctuations and competitive pressures, Thermo Fisher has maintained its commitment to innovation, customer focus, and operational excellence. Its ability to adapt and meet the evolving needs of the scientific and healthcare communities has kept it ahead in the market.